WM Announces Extension of Private Exchange Offer and Consent Solicitation for any and all of Stericycle, Inc.’s $500 million Outstanding 3.875% Senior Notes Due 2029
WM hereby extends the expiration date of the Exchange Offer and Consent Solicitation, which was originally scheduled to be
As of the Early Tender Deadline, the requisite number of consents were received to adopt the Proposed Amendments. WM intends for Stericycle and the trustee for the Stericycle Indenture to execute and deliver a supplemental indenture to amend the Stericycle Indenture giving effect to the Proposed Amendments. However, the Proposed Amendments will only become operative on the settlement date of the Exchange Offer, which is expected to occur on or about the third business day after the Amended Expiration Date, unless WM extends or terminates the Exchange Offer (such date and time, as the same may be extended, the “Settlement Date”), and no earlier than the consummation of WM’s previously announced pending acquisition of Stericycle (the “Transaction”). As a result, the Amended Expiration Date may be further extended by WM in its sole discretion.
As of
Except for the extensions described above, all other terms and conditions of the Exchange Offer and Consent Solicitation set forth in the exchange offer memorandum and consent solicitation statement, dated
Other than the consummation of the Transaction (without which the Exchange Offer will not be consummated), WM may generally waive any condition with respect to the Exchange Offer and Consent Solicitation, in its sole discretion, at any time.
The Exchange Offer is being made only to holders of Stericycle Notes who satisfy the eligibility conditions described under “Disclaimer” below. Holders of Stericycle Notes who desire a copy of the eligibility letter should contact
Holders of Stericycle Notes are advised to check with any bank, securities broker or other intermediary through which they hold Stericycle Notes as to when such intermediary needs to receive instructions from a holder in order for that holder to be able to participate in, or (in the circumstances in which revocation is permitted) revoke their instruction to participate in, the Exchange Offer and Consent Solicitation before the deadlines specified herein and in the Offering Memorandum. The deadlines set by each clearing system for the submission and withdrawal of exchange instructions will also be earlier than the relevant deadlines specified herein and in the Offering Memorandum.
Disclaimer
This press release is issued pursuant to Rule 135c under the Securities Act of 1933, as amended (the “Securities Act”). This press release is neither an offer to sell nor the solicitation of an offer to buy the WM Notes or any other securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which, or to any person to whom, such an offer, solicitation or sale is unlawful. The Exchange Offer has not been and will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and, accordingly, the WM Notes will be subject to transfer restrictions unless and until the WM Notes are registered or exchanged for registered notes. The WM Notes will be issued in reliance upon exemptions from, or in transactions not subject to, registration under the Securities Act. The Exchange Offer is being made only to, and the WM Notes will be offered for exchange only to, holders of Stericycle Notes who are (i) reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, and (ii) outside
The Exchange Offer and Consent Solicitation are being made only pursuant to the Offering Memorandum, as amended hereby. The Offering Memorandum and other documents relating to the Exchange Offer and Consent Solicitation will be distributed only to holders of Stericycle Notes who confirm that they are within the categories of eligible participants in the Exchange Offer. None of WM, its directors or officers, the dealer managers and solicitation agents, the exchange agent, the information agent, the trustees for the WM Notes or the Stericycle Notes, their respective affiliates, or any other person is making any recommendation as to whether holders should tender their Stericycle Notes in the Exchange Offer or consent to the Proposed Amendments in the Consent Solicitation.
This press release, the Offering Memorandum and any other offering material relating to the Exchange Offer are not being made, and have not been approved, by an authorized person for the purposes of Section 21 of the Financial Services and Markets Act 2000. Accordingly, this press release, the Offering Memorandum and any other offering material relating to the Exchange Offer are only being distributed to and are only directed at: (i) persons who are outside the
The complete terms and conditions of the Exchange Offer and Consent Solicitation are set forth in the Offering Memorandum, as amended hereby. The Exchange Offer is only being made pursuant to the Offering Memorandum, as amended hereby. The Exchange Offer is not being made to holders of Stericycle Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. Neither the
ABOUT WM
WM is North America’s leading provider of comprehensive environmental solutions. Previously known as Waste Management and based in
FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements that involve risks and uncertainties, including all statements regarding the consummation and timing of the pending acquisition of Stericycle and the consummation and timing of the Exchange Offer and Consent Solicitation. Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release are discussed in WM’s most recent Annual Report on Form 10-K and subsequent reports on Form 10-Q.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008439786/en/
Analysts
713.265.1656
eegl@wm.com
Media
media@wm.com
Source: